Parsippany, NJ, United States of America

Nagamani Nagabhushan

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 6.9

ph-index = 7

Forward Citations = 209(Granted Patents)


Company Filing History:


Years Active: 1995-2005

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovations of Nagamani Nagabhushan

Introduction

Nagamani Nagabhushan is a prominent inventor based in Parsippany, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of airway diseases. With a total of 10 patents to his name, Nagabhushan's work has had a substantial impact on respiratory health.

Latest Patents

Nagamani Nagabhushan's latest patents include innovative methods for using mometasone furoate to treat upper airway diseases. One patent discloses the administration of aerosolized particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, such as allergic rhinitis and asthma. Another patent focuses on the use of mometasone furoate specifically for treating airway passage and lung diseases, emphasizing the same administration methods.

Career Highlights

Nagamani Nagabhushan has built a successful career at Schering Corporation, where he has been instrumental in developing new therapeutic approaches. His expertise in aerosolized medication has positioned him as a leader in respiratory treatment innovations.

Collaborations

Throughout his career, Nagabhushan has collaborated with notable colleagues, including Joel A Sequeira and Francis M Cuss. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking medical solutions.

Conclusion

Nagamani Nagabhushan's contributions to the field of medicine through his patents and collaborations highlight his dedication to improving respiratory health. His innovative approaches continue to influence the treatment of airway diseases, making a lasting impact on patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…